Laparoscopy has become an indispensable part of modern surgery. Vision is an important and defining element of laparoscopy and significantly affects the outcome of an operation in regard to time, mistakes and precision. Several new imaging systems have become available for laparoscopic surgery, including three-dimensional (3D) high-definition (HD), and two-dimensional (2D) ultra-high-resolution (4K) monitors. In experimental and clinical settings, several studies have been published in recent years suggesting that 3D systems present a number of potential benefits for surgeons and patients compared to the conventional 2D systems. The 3D HD system significantly reduces operation time and blood loss, and additionally shortens hospital stay. However, the performance of 3D systems against the new, ultra-high-definition 4K systems is barely known and highly controversial. There is a paucity of studies comparing these two imaging systems in clinical settings. The goal of this clinical trial is to compare 2D 4K versus 3D HD imaging systems in a complex bariatric surgery, more precisely a gastric bypass operation. The investigators aim to investigate the hypothesis stating that the use of the 3D HD system yields a significant improvement in operating time compared to a 2D 4K system in bariatric laparoscopic surgery. Furthermore, in order to give a comprehensive overview of the comparison of 2D 4K and 3D HD laparoscopy in a clinical setting, the investigators will assess the workload of the surgeon as well as the intraoperative and postoperative complications including the hospitalization time.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
48
All patients involved in the investigation will receive a laparoscopic Roux-en-Y gastric bypass (LRYGB). The interventions are performed by three defined surgeons.
All patients involved in the investigation will receive a laparoscopic Roux-en-Y gastric bypass (LRYGB). The interventions are performed by three defined surgeons.
Clarunis University Center for Gastrointestinal and Liver Diseases
Basel, Switzerland
RECRUITINGOperation time
Operation time (OT) is defined from the beginning of the operation by incision of the skin to the end of the operation by the end of the skin suture.
Time frame: intraoperative
Intraoperative Complications
Intraoperative complications are evaluated descriptively with the surgeon's documentation in the operation report and are also evaluated quantitatively according to blood loss in milliliters. Additionally, if indicated in case of intraoperative complications, a postoperative Hb control is obtained and the Hb decrease determined.
Time frame: Immediately after surgery up to one day postoperatively
Workload of the operating surgeon
The condition of the operating surgeon has a great influence on the outcome of an operation. Especially when using 3D imaging, some undesirable side effects have been reported. In order to determine this once again with modern imaging and performance of a more complex procedure, it is important to determine the subjective workload of the operator. Directly after each operation performed, the operator fills out the Surg-TLX questionnaire, a validated multidimensional surgery-specific workload measure.
Time frame: Immediately after surgery
Postoperative Complications
Postoperative complications are influenced by many factors, including operative time and intraoperative complications. It is important to capture these in order to also compare the postoperative outcomes of the two imaging systems. Postoperative complications are classified and documented until the first follow-up check (after three months postoperatively) in degrees I-V according to the widely used and internationally accepted Clavien Dindo Classification. In addition, the duration of hospitalization is evaluated.
Time frame: Follow-up until the first postoperative Check-up after three months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.